U.S. federal trademark · Serial No. 78649337
Research and development of a platform technology which extends the half life of peptides and small molecules by covalently bonding the peptide to a specific site on blood serum proteins, principally albumin, through the use of reactive chemistry group
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.